drugset

drugset / Trial / NCT00274508

Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

NCT00274508 ↗

Phase 3 Completed 261 enrolled Boehringer Ingelheim

RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate whether tiotropium (Spiriva) improves exercise endurance in patients with COPD

Timeline

Start: 2000-10-10
Primary completion: 2003-01-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tiotropium	Other / unclassified	—	—

Indications